AI Science Tracker
EN

Immune and inflammatory features associated with pyroptosis- and myocardial fibrosis-related genes in HFpEF: a machine learning study

Not stated in the reviewed publisher full text · 2 Oct 2026 · medicine

Discovery

Immune and inflammatory features associated with pyroptosis- and myocardial fibrosis-related genes in HFpEF: a machine learning study

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning feature selection from transcriptomic data proposed a three-gene HFpEF signature; a small clinical cohort linked one marker with HFpEF status and clinical measurements. Results are exploratory: the signature was unstable across resampling, cross-species expression directions differed, and the evidence does not establish causal mechanisms or clinical biomarkers.

Technology: Machine-learning feature selection prioritized candidate genes and fit an exploratory transcriptomic classifier.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning feature selection generated candidate signature findings from transcriptomic cohorts.
Test and result
A three-gene signature was proposed; lower whole-blood PTPN11 was associated with HFpEF status and higher NT-proBNP/CRP in a small clinical cohort.
Limitation / still unknown
The exact gene set showed limited resampling stability; the clinical cohort was small and unmatched, with no causal or clinical diagnostic evidence.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1925067/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full-text Methods and Results; version date and reported validation scope checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.